Brave has introduced a new AI browsing feature that leverages Leo, its privacy-respecting AI assistant, to perform automated ...

VNA-318, an oral brain-penetrant small molecule therapeutic modulates a novel target to reduce inflammation and improve mitochondrial ...

Central banks in big economies are signaling a change of stance, with many now on hold after a long easing cycle, and ...

Jefferies raised the firm’s price target on ImmunityBio (IBRX) to $9 from $8 and keeps a Buy rating on the shares. The firm believes ImmunityBio ...

The phase 1 trial, VNA-318-01, was a randomized, double-blind study involving 92 healthy male subjects. Interim results ...

Zoliflodacin, which will be marketed under the name Nuzolvence, is the first new drug to uniquely target gonorrhea infections ...

A balanced approach using Standard Shopping delivers cleaner traffic and steadier ROAS while letting Performance Max operate ...

Researchers detail FvncBot, SeedSnatcher, and a stronger ClayRat that widen Android data theft and device control tactics.

XmAb819 demonstrated a manageable safety profile with primarily grade 1 or 2 cytokine release syndrome and no neurotoxicity in ccRCC patients. The trial involved 69 patients, with a 25% objective ...

But if you're planning to borrow $500,000, a common loan amount in many competitive markets, you need to know how the latest ...

P4 lets networks finally break free of rigid hardware, adding custom protocols, real-time visibility and smarter security ...

Yang, R. and Wang, H. (2025) Application Research on Close-Range Photogrammetry Acquisition and Processing Technology for ...